SCHEMBL22556296

SCHEMBL22556296

CN(CC1(C(=O)NNC(=O)c2ccccc2Nc2ccc(C(F)(F)F)cc2)CC1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 6/20 0.44
▸ MTOR P42345 1/20 0.43
▸ TAS2R14 Q9NYV8 4/20 0.40
▸ MAPK8 P45983 1/20 0.40
▸ AKR1C3 P42330 1/20 0.40
▸ AKR1C2 P52895 1/20 0.40
▸ THRB P10828 1/20 0.39
▸ MT-CO2 P00403 2/20 0.39
▸ PPARG P37231 2/20 0.39
▸ PPARD Q03181 2/20 0.39
▸ PPARA Q07869 2/20 0.39
▸ NR1H4 Q96RI1 2/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ABCG2 Q9UNQ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22571361 0.88 RXFP1 (0.41) RXFP1MTORTAS2R14MAPK8AKR1C3
SCHEMBL22556362 0.86 RXFP1 (0.46) RXFP1TAS2R14MAPK8THRBMT-CO2
SCHEMBL23701615 0.84 RXFP1 (0.46) RXFP1MTORTAS2R14MAPK8AKR1C3
SCHEMBL23701543 0.83 RXFP1 (0.48) RXFP1MTORTAS2R14MAPK8AKR1C3
SCHEMBL23701523 0.81 RXFP1 (0.47) RXFP1MTORTAS2R14MAPK8AKR1C3
SCHEMBL23701621 0.80 RXFP1 (0.46) RXFP1MTORTAS2R14MAPK8AKR1C3
SCHEMBL22556328 0.80 RXFP1 (0.46) RXFP1MTORTAS2R14MAPK8AKR1C3
SCHEMBL22556300 0.80 RXFP1 (0.49) RXFP1TAS2R14MAPK8AKR1C3AKR1C2
SCHEMBL23701619 0.79 RXFP1 (0.45) RXFP1MTORTAS2R14MAPK8AKR1C3
SCHEMBL22556343 0.79 RXFP1 (0.48) RXFP1TAS2R14MAPK8AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793551-A1 OXADIAZOLE COMPOUNDS Vivace Therapeutics, Inc. (US) 2021-03-24 — — EP disclosed
WO-2019222431-A9 OXADIAZOLE COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2020-10-22 — — WO disclosed
Send feedback